Systems-based approaches to cardiovascular biomarker discovery

Circulation: Cardiovascular Genetics

Volumn 5, Issue 3, 2012, Pages 360-367

  Azuaje, Francisco J ^a   Dewey, Frederick E ^b   Brutsaert, Dirk L ^c   Devaux, Yvan ^a   Ashley, Euan A ^b   Wagner, Daniel R ^a,d  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d Centre Hospitalier   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; COLLAGEN TYPE 2 ALPHA1; DAXX PROTEIN; GELATINASE A; GELATINASE B; HEME OXYGENASE 1; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 4; MID REGION PRO ADRENOMEDULLIN; MOLECULAR MARKER; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN CHAC1; TENASCIN; TENASCIN XB; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZINC FINGER PROTEIN 2; TROPONIN I; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN B;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; HEART FAILURE; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; SYSTEM ANALYSIS; TRANSCRIPTOMICS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; GENOMICS; HUMANS; PROTEOMICS;

EID: 84864632426     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.112.962977     Document Type: Article

References (41)

1. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358: 2148-2159.
2. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med. 2005;352:29-38.
3. Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008;358:2107-2116.
4. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207.
5. Hemingway H, Philipson P, Chen R, Fitzpatrick NK, Damant J, Shipley M, et al. Evaluating the Quality of Research into a Single Prognostic Biomarker: A Systematic Review and Meta-analysis of 83 Studies of C-Reactive Protein in Stable Coronary Artery Disease. PLoS Med. 2010; 7:e1000286.
6. Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Deng MC, Cappola TP, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010;362:1890-1900.
7. Elashoff MR, Wingrove JA, Beineke P, Daniels SE, Tingley WG, Rosenberg S, et al. Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in nondiabetic patients. BMC Med Genomics. 2011;4:26.
8. De Keulenaer GW, Brutsaert DL. Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum. Circulation. 2011;123:1996-2004.
9. Dewey FE, Wheeler MT, Ashley EA. Systems biology of heart failure, challenges and hopes. Curr Opin Cardiol. 2011;26:314-321.
10. Chen JL, Li J, Stadler WM, Lussier YA. Protein-network modeling of prostate cancer gene signatures reveals essential pathways in disease recurrence. J Am Med Inform Assoc. 2011;18:392-402.
11. Lefebvre C, Rajbhandari P, Alvarez MJ, Bandaru P, Lim WK, Sato M, et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol. 2010;6:377.
12. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009; 461:747-753.
13. Vidal M, Cusick ME, Barabási AL. Interactome networks and human disease. Cell. 2011;144:986-998.
14. Azuaje FJ, Rodius S, Zhang L, Devaux Y, Wagner DR. Information encoded in a network of inflammation proteins predicts clinical outcome after myocardial infarction. BMC Med Genomics. 2011;4:59.
15. Devaux Y, Azuaje F, Vausort M, Yvorra C, Wagner DR. Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction. Funct Integr Genomics. 2010;10:329-337.
16. Devaux Y, Bousquenaud M, Rodius S, Marie PY, Maskali F, Zhang L, et al. Transforming growth factor-receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction. BMC Med Genomics. 2011;4:83.
17. Ghosh S, Matsuoka Y, Asai Y, Hsin KY, Kitano H. Software for systems biology: from tools to integrated platforms. Nat Rev Genet. 2011;12: 821-832.
18. Ashley EA, Ferrara R, King JY, Vailaya A, Kuchinsky A, He X, et al. Network analysis of human in-stent restenosis. Circulation. 2006;114: 2644-2654.
19. Jin G, Zhou X, Wang H, Zhao H, Cui K, Zhang XS, et al. The knowledgeintegrated network biomarkers discovery for major adverse cardiac events. J Proteome Res. 2008;7:4013-4021.
20. Azuaje F, Devaux Y, Wagner DR. Integrative pathway-centric modeling of ventricular dysfunction after myocardial infarction. PLoS One. 2010; 5:e9661.
21. Lin CC, Hsiang JT, Wu CY, Zhao H, Cui K, Zhang XS, et al. Dynamic functional modules in co-expressed protein interaction networks of dilated cardiomyopathy. BMC Syst Biol. 2010;4:138.
22. Azuaje F, Devaux Y, Wagner DR. Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network. BMC Syst Biol. 2010 12;4:60.
23. Romanoski CE, Che N, Yin F, Mai N, Pouldar D, Civelek M, et al. Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ Res. 2011;109:e27-e41.
24. Dewey FE, Perez MV, Wheeler MT, Watt C, Spin J, Langfelder P, et al. Gene coexpression network topology of cardiac development, hypertrophy, and failure. Circ Cardiovasc Genet. 2011;4:26-35.
25. Civelek M, Manduchi E, Riley RJ, Stoeckert CJ Jr, Davies PF. Coronary artery endothelial transcriptome in vivo: identification of endoplasmic reticulum stress and enhanced reactive oxygen species by gene connectivity network analysis. Circ Cardiovasc Genet. 2011;4:243-252.
26. Stegemann C, Drozdov I, Shalhoub J, Humphries J, Ladroue C, Didangelos A, et al. Comparative lipidomics profiling of human atherosclerotic plaques. Circ Cardiovasc Genet. 2011;4:232-242.
27. Azuaje F, Devaux Y, Vausort M, Yvorra C, Wagner DR. Transcriptional networks characterize ventricular dysfunction after myocardial infarction: a proof-of-concept investigation. J Biomed Inform. 2010;43:812-819.
28. Nepomuceno-Chamorro I, Azuaje F, Devaux Y, Nazarov PV, Muller A, Aguilar-Ruiz JS, et al. Prognostic transcriptional association networks: a new supervised approach based on regression trees. Bioinformatics. 2011; 27:252-258.
29. Zhou R, Hang P, Zhu W, Su Z, Liang H, Du Z. Whole genome network analysis of ion channels and connexins in myocardial infarction. Cell Physiol Biochem. 2011;27:299-304.
30. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, et al. NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic Acids Res. 2011;39:D1005-D1010.
31. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol. 2010;28:827-838.
32. Diamandis EP. Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst. 2010;102:1462-1467.
33. Azuaje F. Why is it so difficult to data mine relevant genome-scale biomarkers? Expert Opin Med Diagn. 2011;5:1-4.
34. Lam HY, Clark MJ, Chen R, Chen R, Natsoulis G, O'Huallachain M, et al. Performance comparison of whole-genome sequencing platforms. Nat Biotechnol. 2011;30:78-82.
35. Wingrove JA, Daniels SE, Sehnert AJ, Tingley W, Elashoff MR, Rosenberg S, et al. Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ Cardiovasc Genet. 2008;1: 31-38.
36. Rosenberg S, Elashoff MR, Beineke P, Daniels SE, Wingrove JA, Tingley WG, et al. Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients. Ann Intern Med. 2010;153:425-434.
37. Dudley JT, Tibshirani R, Deshpande T, Butte AJ. Disease signatures are robust across tissues and experiments. Mol Syst Biol. 2009;5:307.
38. Marchiò C, Dowsett M, Reis-Filho JS. Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box. BMC Med. 2011;9:41.
39. Chen J, Sam L, Huang Y, Lee Y, Li J, Liu Y, et al. Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures. J Biomed Inform. 2010;43:385-396.
40. Azuaje F, Zheng H, Camargo A, Wang H. Systems-based biological concordance and predictive reproducibility of gene set discovery methods in cardiovascular disease. J Biomed Inform. 2011;44:637-647.
41. Syed Z, Stultz CM, Scirica BM, Guttag JV. Computationally generated cardiac biomarkers for risk stratification after acute coronary syndrome. Sci Transl Med. 2011;3:102ra95.